New drug company to investigate novel multiple sclerosis treatments to halt progression of the disease
Pheno Therapeutics will investigate new multiple sclerosis treatments using technology and expertise from the University of Edinburgh
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Feb 20
Pheno Therapeutics will investigate new multiple sclerosis treatments using technology and expertise from the University of Edinburgh
The study in Finland builds on work of the GDNF drug, which has shown promise in restoring damaged…
18 Feb 20
The EC approval is supported by the results from the Phase III HAWK and HARRIER clinical trials, in…
18 Feb 20
The FDA approval provides OTC access to the Voltaren Arthritis Pain, which has been available only with a…
17 Feb 20
The regulatory approval indicated Tecentriq plus chemotherapy for the treatment of extensive-stage small cell lung cancer (ES-SCLC) in…
17 Feb 20
Mako Medical’s newly launched nutritional DNA test MakoDNA is a genetic test with a personalised meal plan specific…
Solid tumours, and types of breast and lung cancer look set to be the most common indications for…
14 Feb 20
Bristol-Myers Squibb has filed a biologics license application (BLA) with the FDA, which has been accepted by the…
13 Feb 20
Ripretinib is an investigational broad-spectrum KIT and PDGFRα inhibitor, intended for the treatment of advanced gastrointestinal stromal tumours…
13 Feb 20
Dr. Reddy’s will acquire the Wockhardt’s business divisions located in India, and few other territories of Nepal, Sri…